Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19,292
Closed -$1.53M 611
2025
Q2
$1.53M Sell
19,292
-19,107
-50% -$1.52M 0.17% 163
2025
Q1
$3.45M Buy
38,399
+7,461
+24% +$697K 0.35% 94
2024
Q4
$3.08M Sell
30,938
-21,934
-41% -$2.26M 0.35% 86
2024
Q3
$6M Buy
+52,872
New +$6.28M 0.71% 35
2024
Q1
Sell
-6,347
Closed -$692K 512
2023
Q4
$692K Sell
6,347
-16,292
-72% -$1.69M 0.06% 294
2023
Q3
$2.33M Buy
+22,639
New +$2.44M 0.2% 141
2023
Q2
Sell
-73,523
Closed -$7.82M 520
2023
Q1
$7.82M Buy
+73,523
New +$7.94M 0.78% 26
2022
Q3
Sell
-8,784
Closed -$801K 508
2022
Q2
$801K Sell
8,784
-2,346
-21% -$208K 0.16% 181
2022
Q1
$917K Buy
11,130
+7,145
+179% +$563K 0.17% 171
2021
Q4
$305K Buy
+3,985
New +$317K 0.12% 219
2021
Q1
Sell
-12,940
Closed -$1.01M 973
2020
Q4
$1.01M Sell
12,940
-2,098
-14% -$160K 0.15% 150
2020
Q3
$1.19M Buy
+15,038
New +$1.18M 0.78% 23
2020
Q2
Sell
-30,608
Closed -$2.25M 1151
2020
Q1
$2.25M Sell
30,608
-605
-2% -$47.5K 0.49% 40
2019
Q4
$2.71M Buy
+31,213
New +$2.56M 0.27% 81

Other funds holding MRK

FORA Capital's MRK Position: Q3 2025 in Review

FORA Capital sold out of Merck (MRK) in Q3 2025, closing a stake of 19,292 shares — an estimated $1.53M sold.

FORA Capital first reported a position in MRK in Q4 2019 and held it in 14 quarters. The position peaked at $7.82M in Q1 2023. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • FORA Capital reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • FORA Capital sold 19,292 Merck shares in Q3 2025, an estimated $1.53M.
  • FORA Capital first reported a position in Merck in Q4 2019 and held it in 14 quarters.
  • FORA Capital's Merck position peaked at $7.82M in Q1 2023.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on FORA Capital's 13F filing for Q3 2025, filed 13 Nov 2025.